For the year ending 2025-12-31, CRD-B had $8,217K increase in cash & cash equivalents over the period. $94,833K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 19,676 |
| Depreciation and amortization | 40,043 |
| Deferred income taxes | -3,328 |
| Stock-based compensation costs | 5,193 |
| Loss on disposal of property and equipment | -2,718 |
| Contingent earnout adjustments | 537 |
| Accounts receivable, net | -26,369 |
| Unbilled revenues, net | -5,348 |
| Accrued or prepaid income taxes | 1,336 |
| Accounts payable and accrued liabilities | -9,921 |
| Deferred revenues | -2,950 |
| Accrued retirement costs | 7,992 |
| Prepaid expenses and other operating activities | -8,834 |
| Net cash provided by operating activities | 101,847 |
| Acquisitions of property and equipment | 7,014 |
| Capitalization of computer software costs | 31,535 |
| Cash proceeds from disposition of business line | 2,046 |
| Proceeds from settlement of life insurance policies | 295 |
| Net cash used in investing activities | -36,208 |
| Cash dividends paid | 14,328 |
| Payments related to shares received for withholding taxes under employee stock-based compensation plans | 1,531 |
| Proceeds from shares purchased under employee stock-based compensation plans | 2,044 |
| Repurchases of common stock | 10,514 |
| Payments of contingent consideration on acquisitions | 1,326 |
| Increases in short-term and revolving credit facility borrowings | 54,720 |
| Payments on short-term and revolving credit facility borrowings | 84,449 |
| Payments on finance lease obligations | 90 |
| Capitalized loan costs | 2,027 |
| Other financing activities | -119 |
| Net cash used in financing activities | -57,620 |
| Effects of exchange rate changes on cash and cash equivalents | 198 |
| Increase (decrease) in cash, cash equivalents, and restricted cash | 8,217 |
| Cash, cash equivalents, and restricted cash at beginning of year | 56,329 |
| Cash, cash equivalents, and restricted cash at end of year | 64,546 |
CRAWFORD & CO (CRD-B)
CRAWFORD & CO (CRD-B)